The effects of secondhand smoke exposure on infant growth: a prospective cohort study

Azam Baheiraei1, Azar Shamsi2, Afshin Mohsenifar3

  • 1Department of Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran. a.midwifery@gmail.com.

Acta Medica Iranica
|January 20, 2015
PubMed

Insights

Secondhand smoke exposure in infants significantly reduces weight and height growth in the first four months of life. This study highlights the critical impact of environmental tobacco smoke on early childhood development.

Area of Science:

  • Pediatrics
  • Public Health
  • Environmental Health

Background:

  • Maternal and infant exposure to cigarette smoke is a significant public health concern.
  • Limited research exists in Iran on the effects of cigarette smoke on infant growth and development.

Purpose of the Study:

  • To investigate the impact of secondhand smoke exposure on infant growth and development in Iran.
  • To quantify infant exposure levels using urinary cotinine.

Main Methods:

  • A prospective cohort study involving 51 exposed and 51 non-exposed infants.
  • Infants were assessed for weight, height, and head circumference at 5-7 days, 2 months, and 4 months postpartum.
  • Exposure was verified via questionnaires and urinary cotinine levels.

Main Results:

  • Infants exposed to secondhand smoke showed significantly lower weight and height at two and four months (P<0.001).
  • Urinary cotinine levels indicated a reduction in exposure from two to four months postpartum.
  • Head circumference did not show significant differences between groups.

Conclusions:

  • Secondhand smoke exposure in infancy is associated with reduced weight and height growth during the first four months of life.
  • Public health initiatives are needed to reduce infant exposure to environmental tobacco smoke.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
23.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
46